CD8A and neoplasm: In fact, in these mice treatment with either CTX or combined CTX + anti-PDL did not induce any increase in circulating tumor specific CD8+ T cells meaning that TLR-3 signaling in tumor cells is crucially required for the immunostimulatory effect of CTX (Figure 5M).